AstraZeneca's Imfinzi (durvalumab) plus chemotherapy combo has received the European Medicines Agency’s (EMA) Committee for ...

EMA committee recommends approval of AstraZeneca’s Imfinzi in combo with chemotherapy to treat resectable non-small cell lung cancer ...

Imfinzi in combination with chemotherapy has been recommended for approval in the European Union for the treatment of ...

AstraZeneca boasts a remarkably healthy drug portfolio and a pipeline of promising drugs in clinical development. Read why ...

AstraZeneca announced on Monday that Imfinzi, or durvalumab, has been recommended for approval in the European Union for ...

AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been recommended for approval in the European Union (EU) for the treatment of adults with resectable non-small cell lung cancer ...

This approval allows the use of Durvalumab in combination with Tremelimumab, broadening treatment options for patients ...

AstraZeneca Pharma India Ltd has received the nod from the Central Drugs Standard Control Organisation (CDSCO) to import and ...

London open The FTSE 100 is expected to open 45 points higher on Monday, having closed up 0.61% on Friday at 8,809.74.

The approval by the Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Government ...

AstraZeneca Pharma India has announced that the Company has received permission from the CentralDrugs Standard Control ...